Basilea Pharmaceutica’s Asset Purchase Agreement With Amplyx Pharmaceuticals

Marco Zingaro Europe Legal Chronicle
Tagged:

Lenz & Staehelin is advising Pfizer and Amplyx Pharmaceuticals on this transaction.Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into an asset purchase agreement with Amplyx Pharmaceuticals, an…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here